Background
Methods
Lung cancer dataset
Exon array analysis
annmap
[19]). Raw data (Affymetrix CEL files) have been deposited in NCBI’s Gene Expression Omnibus (GEO), and are accessible through GEO Series accession number GSE61676. The exon level probe sets were pre-processed, quality checked and normalized using the RMA procedure (including background correction, quantile normalization and median-polish summarization) as implemented in the R package oligo
[20, 21].Statistical considerations
Computational considerations
ade4
[24], as well as dedicated packages from the Bioconductor project [25] such as the package oligo
for microarray preprocessing [21] and the annotation package annmap
(Homo sapiens database version 86). Functions available in ade4
(including dudi.coa
, wca
, bca
, pcaiv
and pcaivortho
) can theoretically be used to carry out DCCA. However, for reasons of computational efficiency due to the extensive size of exon array datasets, the DCCA algorithm was substantially optimized and a new R extension package dcca
is available (see Additional file 1). Hypothesis testing for the identification of predictive biomarkers was carried out using the following R packages: lme4
, coxme
and multcomp
.Gene functional annotations and validations
Results
Patients characteristics
Variables | |
---|---|
Number of patients (n) | 43 |
Age (median [range]) | 61 (35–78) |
Gender (# male [%]) | 19 (44.2%) |
Stage (n [%]) | IIIb: 4 (9.3%); IV: 39 (90.7%) |
Demonstrable EGFR mutations (n [%]) | 5 (11.6%) |
Disease stabilization at 12 weeks (n [%]) | 23 (53.5%) |
Tumor shrinkage at 12 weeks (median [IQR]), in % of tumor size at baseline | 15.8% (−2.5 to 26.2%) |
Median overall survival (95% CI), in months | 11.1 (10.1–17.9) |
Median time-to-progression under BE (95% CI), in months | 4.0 (2.8–6.0) |
Median time-to-progression under CT (95% CI), in months | 2.6 (1.7–5.7) |
24h gene dysregulation
Ensembl | Gene symbol | Description | Gene dysregulation at 24h |
---|---|---|---|
ENSG00000125257 | ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Up-regulated |
ENSG00000114770 | ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | Down-regulated |
ENSG00000173208 | ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Up-regulated |
ENSG00000151726 | ACSL1 | Acyl-CoA synthetase long-chain family member 1 | Down-regulated |
ENSG00000135074 | ADAM19 | ADAM metallopeptidase domain 19 (meltrin beta) | Down-regulated |
ENSG00000154027 | AK5 | Adenylate kinase 5 | Up-regulated |
ENSG00000151150 | ANK3 | Ankyrin 3, node of Ranvier (ankyrin G) | Up-regulated |
ENSG00000206560 | ANKRD28 | Ankyrin repeat domain 28 | Up-regulated |
ENSG00000118520 | ARG1 | Arginase, liver | Down-regulated |
ENSG00000196914 | ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | Up-regulated |
ENSG00000156802 | ATAD2 | ATPase family, AAA domain containing 2 | Up-regulated |
ENSG00000085224 | ATRX | Alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae) | Up-regulated |
ENSG00000023445 | BIRC3 | baculoviral IAP repeat-containing 3 | Up-regulated |
ENSG00000102010 | BMX | BMX non-receptor tyrosine kinase | Down-regulated |
ENSG00000136492 | BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Up-regulated |
ENSG00000197603 | C5orf42 | Chromosome 5 open reading frame 42 | Up-regulated |
ENSG00000152495 | CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Up-regulated |
ENSG00000137812 | CASC5 | Cancer susceptibility candidate 5 | Up-regulated |
ENSG00000138778 | CENPE | Centromere protein E, 312 kDa | Up-regulated |
ENSG00000198707 | CEP290 | Centrosomal protein 290 kDa | Up-regulated |
ENSG00000106034 | CPED1 | Cadherin-like and PC-esterase domain containing 1 | Up-regulated |
ENSG00000103196 | CRISPLD2 | Cysteine-rich secretory protein LCCL domain containing 2 | Down-regulated |
ENSG00000146122 | DAAM2 | Dishevelled associated activator of morphogenesis 2 | Down-regulated |
ENSG00000035664 | DAPK2 | Death-associated protein kinase 2 | Down-regulated |
ENSG00000137628 | DDX60 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 | Up-regulated |
ENSG00000174485 | DENND4A | DENN/MADD domain containing 4A | Up-regulated |
ENSG00000135905 | DOCK10 | Dedicator of cytokinesis 10 | Up-regulated |
ENSG00000147459 | DOCK5 | Dedicator of cytokinesis 5 | Down-regulated |
ENSG00000088387 | DOCK9 | Dedicator of cytokinesis 9 | Up-regulated |
ENSG00000178904 | DPY19L3 | Dpy-19-like 3 (C. elegans) | Down-regulated |
ENSG00000134765 | DSC1 | Desmocollin 1 | Up-regulated |
ENSG00000135636 | DYSF | Dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive) | Down-regulated |
ENSG00000198919 | DZIP3 | DAZ interacting protein 3, zinc finger | Up-regulated |
ENSG00000102189 | EEA1 | Early endosome antigen 1 | Up-regulated |
ENSG00000151491 | EPS8 | Epidermal growth factor receptor pathway substrate 8 | Up-regulated |
ENSG00000089048 | ESF1 | ESF1, nucleolar pre-rRNA processing protein, homolog (S. cerevisiae) | Up-regulated |
ENSG00000198734 | F5 | Coagulation factor V (proaccelerin, labile factor) | Down-regulated |
ENSG00000140525 | FANCI | Fanconi anemia, complementation group I | Up-regulated |
ENSG00000138829 | FBN2 | Fibrillin 2 (congenital contractural arachnodactyly) | Down-regulated |
ENSG00000139132 | FGD4 | FYVE, RhoGEF and PH domain containing 4 | Down-regulated |
ENSG00000122025 | FLT3 | Fms-related tyrosine kinase 3 | Down-regulated |
ENSG00000161791 | FMNL3 | Formin-like 3 | Up-regulated |
ENSG00000073910 | FRY | Furry homolog (Drosophila) | Down-regulated |
ENSG00000162654 | GBP4 | Guanylate binding protein 4 | Up-regulated |
ENSG00000182885 | GPR97 | G protein-coupled receptor 97 | Down-regulated |
ENSG00000106070 | GRB10 | Growth factor receptor-bound protein 10 | Down-regulated |
ENSG00000084110 | HAL | Histidine ammonia-lyase | Down-regulated |
ENSG00000120694 | HSPH1 | Heat shock 105/110 kDa protein 1 | Up-regulated |
ENSG00000140443 | IGF1R | Insulin-like growth factor 1 receptor | Down-regulated |
ENSG00000197081 | IGF2R | Insulin-like growth factor 2 receptor | Down-regulated |
ENSG00000115604 | IL18R1 | Interleukin 18 receptor 1 | Down-regulated |
ENSG00000115594 | IL1R1 | Interleukin 1 receptor, type I | Down-regulated |
ENSG00000115590 | IL1R2 | Interleukin 1 receptor, type II | Down-regulated |
ENSG00000109452 | INPP4B | Inositol polyphosphate-4-phosphatase, type II, 105 kDa | Up-regulated |
ENSG00000102445 | KIAA0226L | KIAA0226-like | Down-regulated |
ENSG00000137261 | KIAA0319 | KIAA0319 | Down-regulated |
ENSG00000110318 | KIAA1377 | KIAA1377 | Up-regulated |
ENSG00000054523 | KIF1B | Kinesin family member 1B | Down-regulated |
ENSG00000138182 | KIF20B | Kinesin family member 20B | Up-regulated |
ENSG00000139116 | KIF21A | Kinesin family member 21A | Up-regulated |
ENSG00000068796 | KIF2A | Kinesin heavy chain member 2A | Up-regulated |
ENSG00000184445 | KNTC1 | Kinetochore associated 1 | Up-regulated |
ENSG00000126777 | KTN1 | Kinectin 1 (kinesin receptor) | Up-regulated |
ENSG00000123384 | LRP1 | Low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) | Down-regulated |
ENSG00000186205 | MARC1 | Mitochondrial amidoxime reducing component 1 | Down-regulated |
ENSG00000257335 | MGAM | Maltase-glucoamylase (alpha-glucosidase) | Down-regulated |
ENSG00000171843 | MLLT3 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 | Up-regulated |
ENSG00000196549 | MME | Membrane metallo-endopeptidase | Down-regulated |
ENSG00000100985 | MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase) | Down-regulated |
ENSG00000051825 | MPHOSPH9 | M-phase phosphoprotein 9 | Up-regulated |
ENSG00000138119 | MYOF | Myoferlin | Up-regulated |
ENSG00000049759 | NEDD4L | Neural precursor cell expressed, developmentally down-regulated 4-like | Up-regulated |
ENSG00000184613 | NELL2 | NEL-like 2 (chicken) | Up-regulated |
ENSG00000173145 | NOC3L | Nucleolar complex associated 3 homolog (S. cerevisiae) | Up-regulated |
ENSG00000179299 | NSUN7 | NOL1/NOP2/Sun domain family, member 7 | Down-regulated |
ENSG00000111581 | NUP107 | Nucleoporin 107 kDa | Up-regulated |
ENSG00000159339 | PADI4 | Peptidyl arginine deiminase, type IV | Down-regulated |
ENSG00000123836 | PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | Down-regulated |
ENSG00000075651 | PLD1 | Phospholipase D1, phosphatidylcholine-specific | Down-regulated |
ENSG00000101868 | POLA1 | Polymerase (DNA directed), alpha 1 | Up-regulated |
ENSG00000080839 | RBL1 | Retinoblastoma-like 1 (p107) | Up-regulated |
ENSG00000257743 | RP11-1220K2.2 | Putative inactive maltase-glucoamylase-like protein LOC93432 | Down-regulated |
ENSG00000226891 | RP11-182I10.3 | Uncharacterized LOC101927084 | Down-regulated |
ENSG00000258476 | RP11-76E17.3 | NA | Down-regulated |
ENSG00000140386 | SCAPER | S phase cyclin A-associated protein in the ER | Up-regulated |
ENSG00000018280 | SLC11A1 | Solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | Down-regulated |
ENSG00000140090 | SLC24A4 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 | Down-regulated |
ENSG00000112053 | SLC26A8 | Solute carrier family 26, member 8 | Down-regulated |
ENSG00000157800 | SLC37A3 | Solute carrier family 37 (glycerol-3-phosphate transporter), member 3 | Down-regulated |
ENSG00000136824 | SMC2 | Structural maintenance of chromosomes 2 | Up-regulated |
ENSG00000163029 | SMC6 | Structural maintenance of chromosomes 6 | Up-regulated |
ENSG00000009694 | TENM1 | Teneurin transmembrane protein 1 | Down-regulated |
ENSG00000169902 | TPST1 | Tyrosylprotein sulfotransferase 1 | Down-regulated |
ENSG00000198677 | TTC37 | Tetratricopeptide repeat domain 37 | Up-regulated |
ENSG00000155657 | TTN | Titin | Up-regulated |
ENSG00000120800 | UTP20 | UTP20, small subunit (SSU) processome component, homolog (yeast) | Up-regulated |
ENSG00000197969 | VPS13A | Vacuolar protein sorting 13 homolog A (S. cerevisiae) | Up-regulated |
ENSG00000163625 | WDFY3 | WD repeat and FYVE domain containing 3 | Down-regulated |
ENSG00000213799 | ZNF845 | Zinc finger protein 845 | Up-regulated |
ENSG00000167232 | ZNF91 | Zinc finger protein 91 | Up-regulated |
Gene expression predictive value
Time | Endpointa
| Gene symbols | KEGG pathway enrichment |
---|---|---|---|
Baseline | TS12 | ANO2, VPS13D, EML1, C22orf31, FERMT1, SFRP4, SUPT6H, GYS2, THBS4, ATP6V1B1, TCF21, ESRRB, NEUROD4, SOX15, GATA5, PRRC2B, SLC7A10, LOXL4, DISP2, TRIM7, DRD2, GPHA2, KCTD15, PAQR4, ANKZF1, SHROOM1, FABP7, FBXL21, KCNK5, MBL2, LY6D, VASN, FSTL5, MECP2, ROR2, TPT1-AS1, DCDC1, HS6ST2, HSPB7, NWD2, OR5M3, SLC35E3, UNC119B, OR10AB1P, UMODL1, ERN1, RNF151, CALHM1, TMPRSS12, KLK12, KRT14, LINC01551, NWD1, C15orf52, IL1RAPL2, TRRAP, TPK1, MYO18A, DSCR8, B3GNT6, RNA5SP430, C1orf132, PPAPDC1A, BTBD17, LAYN, CST9LP1, ST8SIA6-AS1, AL592528.1, RP11-337C18.4, GAPDHP44, HAUS7, AC010904.1, CELA3B, RP1-288M22.1, U3, CTA-929C8.7, ARSEP1, UBE2D3P4, RP11-38C18.2, RP11-94M14.2, AC007312.3, LINC00237, RP11-66N5.2, LINC01375, C1DP4, RP11-20P5.2, RP5-888M10.2, AC105443.2, FGFR1OP2P1, RP5-855F14.2, TFAMP1, POLR3KP1, CRYGFP, TBC1D3P7, RP11-336N8.1, DCUN1D2-AS, RP11-528G1.2, ZBTB22, TSPY15P, RP11-98G13.1, AC007679.4, KCNQ1DN, RN7SL549P, SMKR1, PNMA2, PI4KA, RP11-520P18.1, RP11-572M11.3, OR10J7P, RP11-331K21.1, RP11-340A13.1, LINC00977, RP3-368B9.2, SNORA18, HNRNPCP8, MPV17L2, NAV2-AS5, CTD-2517M22.14, ENPP7P5, RP11-150C16.1, HNRNPA3P10, RP11-316E14.2, RP11-566K19.5, RP11-521O16.1, RP11-616M22.7, RP11-523L20.2, AC009120.4, RP11-106M3.3, RP11-553K8.5, RP11-189E14.4, RP11-520P18.5, SAMD11P1, RP11-286N3.2, SNRPCP4, RP11-343K8.3, AC005307.3, AC010524.4, CTB-31C7.3, WI2-80269A6.1, RP11-401N16.1, RP11-416H1.1, RP11-1072C15.7 | Phagosome (hsa04145, \(p=0.052\)) Protein digestion and absorption (hsa04974, \(p=0.058\)) |
DS12 | – | – | |
OS | CASC1, HIST1H1A, FAM86C2P, Y_RNA, IGHV5-51, RP11-174G6.1, HNRNPA1P63, EEF1B2P1, RP3-403L10.3, RPL7P53, IGKV1-5, MRPS36P2, RP11-415I12.3, RNU6-412P, RNU6-1224P, RP11-61G23.2, CTD-2547H18.1, RP11-295G12.1, ZNF23 | – | |
TTPBE | BDKRB1, NRN1, LAMC1, ZNF462, LRRC43, SGSM1, FSCN2, C9orf92, RNU6-83P, RPL7AP14, RP11-793K1.1, RP3-433F14.1, RP1-292B18.4, AC098592.7, AC114812.8, TOMM20P1, LL22NC03-88E1.17, C12orf77, RP1-213J1P__B.1, LINC01038, MARK2P12, XRCC6P3, SHC1P1, RP3-463P15.1, LL0XNC01-116E7.2, COL4A2-AS1, CYCSP44, RAC1P8, SLMO2-ATP5E, AF127577.12, STARD13-AS, RN7SL797P, RN7SL598P, RP11-544A12.8, RP11-415I12.3, RP11-61G23.2, RP11-6B19.3, RP11-136F16.2, CASC18, AC002306.1, RP11-552E10.1, RP11-361M10.3, RP11-203B7.2, RP11-475B2.1, RP11-763E3.1, RP13-516M14.2, RP11-820I16.1 | – | |
TTPCT | KRTAP2-3, AC090957.2, KALP, RP11-157I4.4, TSIX | – | |
24h after initiation of BE | TS12 | PDZD4, SH3BP1, CALD1, SPX, MAPKBP1, MMRN1, EGF, PLOD2, ANKRD61, FZD5, CLEC1B, SLC39A13, SMCO4, BCRP2, TSNARE1, TDRP, TOP1MT, TPTE2P3, RNU105C, Y_RNA, RN7SKP257, AC006988.1, ATP5HP3, RNU6-887P, RP11-361F15.2, BANF1P2, AC099344.2, LINC00884, DDX39BP2, RP11-486M23.1, RP11-167N24.3, RP11-693J15.3, RP11-433P17.3 |
Pathways in cancer (hsa05200, \(p=0.031\)) |
DS12 | – | – | |
OS | MYO1C, Y_RNA, DEFB134, Y_RNA, IGLV3-21, IGLC7, IGHA2, IGHA1, IGHV3-15, IGHV3-23, IGHV5-51, SOD1P1, AC016768.1, LINC01032, ZSCAN31, RP11-169N13.4, IGKV1-5, IGHV3-65, IGLC4, RP11-280K24.1 | – | |
TTPBE | TNMD, TSPAN9, PRICKLE3, RAD51, MCM10, TCF3, ATP2A3, OPHN1, FBXL19, PCK2, PLTP, E2F1, PCYT1B, CKM, APBA1, CNTNAP1, FOXM1, KIF20A, CIT, HJURP, E2F8, KLF16, APOC1, ATP8B3, EPHB2, CTIF, TICRR, CTU1, CPXCR1, GRIK4, C16orf78, CKB, VKORC1, TK1, METTL7B, MZB1, ZNF296, RRM2, JUP, PCP2, CADM2, SLC25A22, KLHL28, GJC1, MARCH11, GAS2L1, MITF, HIST1H2BM, SLC25A29, SRC, MYO1C, RNU12-2P, Y_RNA, D86998.1, IGLV6-57, IGLV3-21, IGHG1, IGHJ1, IGHV6-1, IGHV4-28, AP005482.3, RP3-407E4.4, RP11-535M15.1, IPPKP1, FAM195B, RP11-69C17.2, HDGFP1, SCAMP4, RD3L, TUBB4AP1, SDAD1P2, RP11-321L2.1, SPATA31B1P, AC005772.2, RP11-22C8.1, VN1R38P, ITGA9-AS1, NIFK-AS1, B3GNT9, RP11-252M21.6, RN7SL60P, RP11-266N13.2, RP11-517I3.1, RP11-364C11.2, RACGAP1P, RP11-545N8.3, RP11-81A1.3, RP11-2C24.5, AF213884.2, PRKCA-AS1, CTD-2319I12.2 | Melanoma (hsa05218, \(p=0.029\)) Pancreatic cancer (hsa05212, \(p=0.029\)) PPAR signaling cancer (hsa03320, \(p=0.029\)) arginine and proline metabolism (hsa00330, \(p=0.029\)) Pathways in cancer (hsa05200, \(p=0.029\)) Pyrimidine metabolism (hsa00240, \(p=0.041\)) | |
TTPCT | TTTY14, MTND1P4, RP11-875H7.2, LINC01021, AC008565.1, LINC01486 | – |